Showing results (831-840 of 1,221) with videos related to

Sort By:
Pageof 123
Breast Cancer Research and Treatment|April 22, 2011
Genomic profiling of mitochondrion-rich breast carcinoma: chromosomal changes may be relevant for mitochondria accumulation and tumour biologyFelipe C Geyer, Dario de Biase, Maryou B K Lambros, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 16, 2017
The European Society for Medical Oncology (ESMO) Precision Medicine GlossaryL R Yates, J Seoane, C Le Tourneau, et al.
Human Molecular Genetics|October 11, 2012
Somatic complex I disruptive mitochondrial DNA mutations are modifiers of tumorigenesis that correlate with low genomic instability in pituitary adenomasIvana Kurelac, Alan MacKay, Maryou B K Lambros, et al.
Journal of Applied Animal Welfare Science : JAAWS|August 1, 2025
Catnip (Nepeta cataria) and Feline Facial Pheromone Have No Effect on Clinical or Behavioral Parameters of Cats in Hospital EnvironmentO Branco Luana, L Macedo Mônica, A M da Silva Natascha, et al.
Mycoses|May 3, 2007
Mycological evaluation of bronchoalveolar lavage in cats with respiratory signs from Rio de Janeiro, BrazilL R P Leme, T M P Schubach, I B Santos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Perilobar nephrogenic rests are nonobligate molecular genetic precursor lesions of insulin-like growth factor-II-associated Wilms tumorsRaisa Vuononvirta, Neil J Sebire, Anthony R Dallosso, et al.
Gynecologic Oncology|February 18, 2024
Adenoid cystic carcinoma of the Bartholin's gland is underpinned by MYB- and MYBL1- rearrangementsJacqueline Feinberg, Arnaud Da Cruz Paula, Edaise M da Silva, et al.
Histopathology|March 8, 2019
Micropapillary variant of mucinous carcinoma of the breast shows genetic alterations intermediate between those of mucinous carcinoma and micropapillary carcinomaFresia Pareja, Pier Selenica, David N Brown, et al.
Cancer Research|February 25, 2010
FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancerNicholas Turner, Alex Pearson, Rachel Sharpe, et al.
Cancer Research|November 3, 2007
The collagen receptor Endo180 (CD280) Is expressed on basal-like breast tumor cells and promotes tumor growth in vivoDirk Wienke, Gareth C Davies, Damian A Johnson, et al.
Pageof 123